Logo image of TCDA

TRICIDA INC (TCDA) Stock Price, Quote, News and Overview

NASDAQ:TCDA - Nasdaq - US89610F1012 - Common Stock - Currency: USD

0.108  -0.01 (-10%)

After market: 0.084 -0.02 (-22.22%)

TCDA Quote, Performance and Key Statistics

TRICIDA INC

NASDAQ:TCDA (1/23/2023, 8:00:00 PM)

After market: 0.084 -0.02 (-22.22%)

0.108

-0.01 (-10%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High13.85
52 Week Low0.09
Market Cap6.02M
Shares55.69M
Float51.35M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)03-27 2023-03-27
IPO06-28 2018-06-28


TCDA short term performance overview.The bars show the price performance of TCDA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

TCDA long term performance overview.The bars show the price performance of TCDA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of TCDA is 0.108 USD. In the past month the price decreased by -34.62%. In the past year, price decreased by -98.91%.

TRICIDA INC / TCDA Daily stock chart

TCDA Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 67.21 829.40B
NVO NOVO-NORDISK A/S-SPONS ADR 27.44 390.99B
JNJ JOHNSON & JOHNSON 16.25 390.76B
AZN ASTRAZENECA PLC-SPONS ADR 20.56 230.17B
MRK MERCK & CO. INC. 11.71 226.40B
NVS NOVARTIS AG-SPONSORED ADR 13.77 215.98B
PFE PFIZER INC 8.46 149.04B
SNY SANOFI-ADR 13.58 136.54B
BMY BRISTOL-MYERS SQUIBB CO 48.97 113.23B
GSK GSK PLC-SPON ADR 7.78 74.77B
ZTS ZOETIS INC 27.1 72.39B
TAK TAKEDA PHARMACEUTIC-SP ADR 31.95 44.58B

About TCDA

Company Profile

TCDA logo image Tricida, Inc. is a pharmaceutical company. The company is headquartered in South San Francisco, California and currently employs 57 full-time employees. The company went IPO on 2018-06-28. TRC101, is a non-absorbed, orally administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal (GI), tract. Its Veverimer, is a low-swelling, spherical polymer bead that is approximately 100 micrometers in diameter, which is a single, molecular weight, crosslinked polyamine molecule. The company is conducting renal outcomes clinical trial, VALOR-CKD (TRCA-303), to determine if veverimer slows CKD progression in patients with metabolic acidosis associated with CKD. The firm's VALOR-CKD trial is a randomized, double-blind, placebo-controlled, time-to-event trial.

Company Info

TRICIDA INC

7000 Shoreline Court, Suite 201

South San Francisco CALIFORNIA 94080 US

CEO: Gerrit Klaerner

Employees: 57

Company Website: https://www.tricida.com/

Phone: 14154297800.0

TRICIDA INC / TCDA FAQ

What is the stock price of TRICIDA INC today?

The current stock price of TCDA is 0.108 USD. The price decreased by -10% in the last trading session.


What is the ticker symbol for TRICIDA INC stock?

The exchange symbol of TRICIDA INC is TCDA and it is listed on the Nasdaq exchange.


On which exchange is TCDA stock listed?

TCDA stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for TRICIDA INC stock?

8 analysts have analysed TCDA and the average price target is 19.72 USD. This implies a price increase of 18159.26% is expected in the next year compared to the current price of 0.108. Check the TRICIDA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is TRICIDA INC worth?

TRICIDA INC (TCDA) has a market capitalization of 6.02M USD. This makes TCDA a Nano Cap stock.


How many employees does TRICIDA INC have?

TRICIDA INC (TCDA) currently has 57 employees.


What are the support and resistance levels for TRICIDA INC (TCDA) stock?

TRICIDA INC (TCDA) has a resistance level at 0.16. Check the full technical report for a detailed analysis of TCDA support and resistance levels.


Should I buy TRICIDA INC (TCDA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TRICIDA INC (TCDA) stock pay dividends?

TCDA does not pay a dividend.


When does TRICIDA INC (TCDA) report earnings?

TRICIDA INC (TCDA) will report earnings on 2023-03-27.


What is the Price/Earnings (PE) ratio of TRICIDA INC (TCDA)?

TRICIDA INC (TCDA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.36).


TCDA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

TCDA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TCDA. Both the profitability and financial health of TCDA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TCDA Financial Highlights

Over the last trailing twelve months TCDA reported a non-GAAP Earnings per Share(EPS) of -2.36. The EPS increased by 32.38% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%44.3%
Sales Q2Q%N/A
EPS 1Y (TTM)32.38%
Revenue 1Y (TTM)N/A

TCDA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 45% to TCDA. The Buy consensus is the average rating of analysts ratings from 8 analysts.


Ownership
Inst OwnersN/A
Ins Owners5.62%
Short Float %N/A
Short RatioN/A
Analysts
Analysts45
Price Target19.72 (18159.26%)
EPS Next Y38.93%
Revenue Next YearN/A